Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
Chris M. Storgard, … , Robert I. Fox, David A. Cheresh
Chris M. Storgard, … , Robert I. Fox, David A. Cheresh
Published January 1, 1999
Citation Information: J Clin Invest. 1999;103(1):47-54. https://doi.org/10.1172/JCI3756.
View: Text | PDF
Article Article has an altmetric score of 6

Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist

  • Text
  • PDF
Abstract

Rheumatoid arthritis (RA) is an inflammatory disease associated with intense angiogenesis and vascular expression of integrin αvβ3. Intra-articular administration of a cyclic peptide antagonist of integrin αvβ3 to rabbits with antigen-induced arthritis early in disease resulted in inhibition of synovial angiogenesis and reduced synovial cell infiltrate, pannus formation, and cartilage erosions. These effects were not associated with lymphopenia or impairment of leukocyte function. Furthermore, when administered in chronic, preexisting disease, the αvβ3 antagonist effectively diminished arthritis severity and was associated with a quantitative increase in apoptosis of the angiogenic blood vessels. Therefore, angiogenesis appears to be a central factor in the initiation and persistence of arthritic disease, and antagonists of integrin αvβ3 may represent a novel therapeutic strategy for RA.

Authors

Chris M. Storgard, Dwayne G. Stupack, Alfred Jonczyk, Simon L. Goodman, Robert I. Fox, David A. Cheresh

×

Total citations by year

Year: 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1995 1991 Total
Citations: 3 3 3 3 6 3 3 2 2 5 9 6 117 6 9 17 11 18 15 13 18 21 22 23 12 1 1 1 353
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2003 (18)

Title and authors Publication Year
Essential Role of a Cryptic Epitope, SLAYGLR within Osteopontin in Murine Model of Rheumatoid Arthritis
Nobuchika Yamamoto, Fumihiko Sakai, Shigeyuki Kon, Junko Morimoto, Chiemi Kimura, Harumi Yamazaki, Ikuko Okazaki, Nobuo Seki, Takashi Fujii, Toshimitsu Uede
Journal of Clinical Investigation 2003
Signaling through JAM-1 and alphavbeta3 is required for the angiogenic action of bFGF: dissociation of the JAM-1 and alphavbeta3 complex
MU Naik, SA Mousa, CA Parkos, UP Naik
Blood 2003
The therapeutic potential of TNF-α blockade in rheumatoid arthritis
E Paleolog
Expert Opinion on Investigational Drugs 2003
The airway epithelium: Structural and functional properties in health and disease
DA KNIGHT, ST HOLGATE
Respirology 2003
Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha
EM Gravallese, AR Pettit, R Lee, R Madore, C Manning, A Tsay, J Gaspar, MB Goldring, SR Goldring, P Oettgen
Annals of the rheumatic diseases 2003
Angiogenesis as a target in rheumatoid arthritis
AE Koch
Annals of the rheumatic diseases 2003
Highly potent and selective αVβ3-receptor antagonists: solid-phase synthesis and SAR of 1-substituted 4-amino-1H-pyrimidin-2-ones
C Zechel, G Backfisch, J Delzer, H Geneste, C Graef, W Hornberger, A Kling, UE Lange, A Lauterbach, W Seitz, T Subkowski
Bioorganic & Medicinal Chemistry Letters 2003
Design and synthesis of 1,5- and 2,5-substituted tetrahydrobenzazepinones as novel potent and selective integrin αVβ3 antagonists
A Kling, G Backfisch, J Delzer, H Geneste, C Graef, W Hornberger, UE Lange, A Lauterbach, W Seitz, T Subkowski
Bioorganic & Medicinal Chemistry 2003
Recent data on the role for angiogenesis in rheumatoid arthritis
G Clavel, N Bessis, MC Boissier
Joint Bone Spine 2003
The role of COX-2 in angiogenesis and rheumatoid arthritis☆
JM Woods, A Mogollon, MA Amin, RJ Martinez, AE Koch
Experimental and Molecular Pathology 2003
Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis
MD Bandt, MH Mahdi, V Ollivier, M Grossin, M Dupuis, M Gaudry, P Bohlen, KE Lipson, A Rice, Y Wu, MA Gougerot-Pocidalo, C Pasquier
Journal of immunology (Baltimore, Md. : 1950) 2003
Avancées récentes sur l’implication de l’angiogenèse dans la polyarthrite rhumatoïde
G Clavel, N Bessis, MC Boissier
Revue du Rhumatisme 2003
Apoptotic cues from the extracellular matrix: regulators of angiogenesis
DG Stupack, DA Cheresh
Oncogene 2003
Inhibition of integrin ?5?1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice
O Stoeltzing, W Liu, N Reinmuth, F Fan, GC Parry, AA Parikh, MF McCarty, CD Bucana, AP Mazar, LM Ellis
International Journal of Cancer 2003
Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease
MA Cimmino, S Innocenti, F Livrone, F Magnaguagno, E Silvestri, G Garlaschi
Arthritis & Rheumatism 2003
JAM-1 Regulation of Endothelial Cell Migration: Implications for Angiogenesis
LV Parise
Arteriosclerosis, thrombosis, and vascular biology 2003
Docking Studies on α v β 3 Integrin Ligands: Pharmacophore Refinement and Implications for Drug Design
L Marinelli, A Lavecchia, KE Gottschalk, E Novellino, H Kessler
Journal of Medicinal Chemistry 2003
[ 18 F]Galacto-RGD: Synthesis, Radiolabeling, Metabolic Stability, and Radiation Dose Estimates
R Haubner, B Kuhnast, C Mang, WA Weber, H Kessler, HJ Wester, M Schwaiger
Bioconjugate Chemistry 2003

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 24 patents
48 readers on Mendeley
See more details